NL-OMON28744
Not yet recruiting
Not Applicable
IMProving Adherence in chronic hepatitis C patients on peg-interferon - ribavirin combination Therapy.
niversity Medical Center Utrecht (UMCU)0 sites100 target enrollmentStarted: TBDLast updated:
Overview
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- niversity Medical Center Utrecht (UMCU)
- Enrollment
- 100
Overview
Brief Summary
/A
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1\. CHC patients eligible for antiviral treatment with PEG\-interferon and ribavirin (PegIntron®/ Rebetol®);
- •2\. 18 years of age or older;
Exclusion Criteria
- •Contra\-indications for antiviral treatment.
Investigators
Similar Trials
Completed
Not Applicable
Adherence in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04281)(COMPLETED)Hepatitis C, ChronicHepacivirusNCT00704522Merck Sharp & Dohme LLC601
Terminated
Not Applicable
Adherence in Patients Receiving PegIntron and Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04206)Hepatitis C, ChronicHepacivirusNCT00723879Merck Sharp & Dohme LLC115
Completed
Not Applicable
Multidisciplinary Support Program in Chronic Hepatitis CHepatitis C, ChronicNCT01850745Parc de Salut Mar447
Completed
Not Applicable
Retreatment of chronic hepatitis C patients with pegylated interferon, ribavirin and amantadine; A pilot study to establishif initial drop in viral load is predictive for sustained virological response.Chronic hepatitis C infectionNL-OMON27702Schering-Plough61
Withdrawn
Not Applicable
Improving treatment adherence in chronically ill adolescents and young adults.NL-OMON46629Academisch Medisch Centrum500